Annotation (Toggle Detail/Summary View) Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:732751 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A1 mRNA | CTD | PMID:22079256 | (R)-pantothenic acid | multiple interactions | ISO | RGD:732752 | 6480464 | [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA | CTD | PMID:20505214 | (S)-amphetamine | increases expression | ISO | RGD:732752 | 6480464 | Dextroamphetamine results in increased expression of NR4A1 mRNA | CTD | PMID:19194377 | (S)-nicotine | increases expression | ISO | RGD:732752 | 6480464 | Nicotine results in increased expression of NR4A1 mRNA | CTD | PMID:17456735 | (S)-nicotine | decreases expression | ISO | RGD:732752 | 6480464 | Nicotine results in decreased expression of NR4A1 mRNA | CTD | PMID:21955143 | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | RGD:732752 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of NR4A1 mRNA | CTD | PMID:20826375 | 1,2,4-trimethylbenzene | increases expression | EXP | | 6480464 | pseudocumene results in increased expression of NR4A1 protein | CTD | PMID:17337753 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:732752 | 6480464 | Ethinyl Estradiol results in increased expression of NR4A1 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:732752 | 6480464 | Ethinyl Estradiol affects the expression of NR4A1 mRNA | CTD | PMID:17555576 | 17beta-estradiol | decreases expression | ISO | RGD:732751 | 6480464 | Estradiol results in decreased expression of NR4A1 mRNA | CTD | PMID:16514628 | 17beta-estradiol | multiple interactions | ISO | RGD:732752 | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of NR4A1 mRNA] | CTD | PMID:20667977 | 17beta-estradiol | increases expression | ISO | RGD:732752 | 6480464 | Estradiol results in increased expression of NR4A1 mRNA | CTD | PMID:20667977 PMID:20826375 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of NR4A1 mRNA | CTD | PMID:20068009 | 17beta-estradiol | increases expression | ISO | RGD:732752 | 6480464 | Estradiol results in increased expression of NR4A1 mRNA | CTD | PMID:20826375 | 17beta-estradiol | affects expression | ISO | RGD:732752 | 6480464 | Estradiol affects the expression of NR4A1 mRNA | CTD | PMID:15598610 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:732751 | 6480464 | Dapsone analog inhibits the reaction [Metribolone results in increased expression of NR4A1 mRNA] | CTD | PMID:21440447 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:732751 | 6480464 | Metribolone results in increased expression of NR4A1 mRNA | CTD | PMID:21440447 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732752 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NR4A1 mRNA | CTD | PMID:16962184 | 2-butoxyethanol | increases expression | ISO | RGD:732752 | 6480464 | n-butoxyethanol results in increased expression of NR4A1 mRNA | CTD | PMID:19812364 | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of NR4A1 mRNA | CTD | PMID:19643169 | 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:732752 | 6480464 | 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine inhibits the reaction [[NR4A1 co-treated with THRA] results in increased expression of HSD3B1 mRNA]]; more ... | CTD | PMID:21726595 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:732752 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NR4A1 mRNA | CTD | PMID:20188158 | 3-methylcholanthrene | decreases expression | ISO | RGD:732752 | 6480464 | Methylcholanthrene results in decreased expression of NR4A1 mRNA | CTD | PMID:20713471 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:732752 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of NR4A1 mRNA | CTD | PMID:19191707 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:732751 | 6480464 | Fenretinide results in increased expression of NR4A1 mRNA; more ... | CTD | PMID:21319187 | 4-hydroxyphenyl retinamide | affects response to substance | ISO | RGD:732751 | 6480464 | NR4A1 protein affects the susceptibility to Fenretinide | CTD | PMID:19912993 | 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:732751 | 6480464 | NR4A1 protein affects the reaction [Fenretinide results in increased expression of CASP3 protein modified form] | CTD | PMID:19912993 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:732751 | 6480464 | Fenretinide results in increased expression of NR4A1 mRNA | CTD | PMID:19912993 PMID:21319187 | 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:732751 | 6480464 | [Fenretinide co-treated with scriptaid] affects the localization of NR4A1 protein; more ... | CTD | PMID:21319187 | 4-hydroxyphenyl retinamide | affects localization | ISO | RGD:732751 | 6480464 | Fenretinide affects the localization of NR4A1 protein | CTD | PMID:21319187 | 5-azacytidine | multiple interactions | ISO | RGD:732751 | 6480464 | [metacept-1 co-treated with Azacitidine] results in increased expression of NR4A1 | CTD | PMID:19148494 | 5-fluorouracil | affects expression | ISO | RGD:732751 | 6480464 | Fluorouracil affects the expression of NR4A1 mRNA | CTD | PMID:16557594 PMID:15205334 | 5-fluorouracil | affects expression | ISO | RGD:732751 | 6480464 | Fluorouracil affects the expression of NR4A1 mRNA | CTD | PMID:15205334 PMID:16557594 | 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:732752 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 protein | CTD | PMID:21726595 | 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:732751 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 mRNA | CTD | PMID:22079614 | acetaldehyde | increases expression | ISO | RGD:732751 | 6480464 | Acetaldehyde results in increased expression of NR4A1 mRNA | CTD | PMID:23416264 | acrolein | increases expression | ISO | RGD:732751 | 6480464 | Acrolein results in increased expression of NR4A1 mRNA; more ... | CTD | PMID:20015449 | afimoxifene | increases expression | ISO | RGD:732751 | 6480464 | 4-hydroxytamoxifen results in increased expression of NR4A1 mRNA | CTD | PMID:16514628 | all-trans-retinoic acid | multiple interactions | ISO | RGD:732751 | 6480464 | leptomycin B inhibits the reaction [Tretinoin affects the localization of [NR4A1 protein binds to RXRA protein]]; more ... | CTD | PMID:14592536 | all-trans-retinoic acid | multiple interactions | ISO | RGD:732751 | 6480464 | Tretinoin inhibits the reaction [Indomethacin results in increased expression of NR4A1 mRNA] | CTD | PMID:10919358 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NR4A1 mRNA | CTD | PMID:16483693 | amphetamine | multiple interactions | EXP | | 6480464 | Amphetamine promotes the reaction [Ibotenic Acid results in decreased expression of NR4A1 mRNA] | CTD | PMID:14622910 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of NR4A1 mRNA | CTD | PMID:12638131 PMID:14622910 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of NR4A1 mRNA | CTD | PMID:14622910 PMID:12638131 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of NR4A1 mRNA | CTD | PMID:15183010 | arsenic atom | decreases expression | ISO | RGD:732752 | 6480464 | Arsenic results in decreased expression of NR4A1 mRNA | CTD | PMID:19654921 | arsenite(3-) | multiple interactions | ISO | RGD:732752 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of NR4A1 mRNA | CTD | PMID:15894712 | arsenite(3-) | decreases expression | ISO | RGD:732752 | 6480464 | arsenite results in decreased expression of NR4A1 mRNA | CTD | PMID:15894712 | ATP | increases expression | EXP | | 6480464 | Adenosine Triphosphate results in increased expression of NR4A1 mRNA | CTD | PMID:10723097 | atrazine | increases expression | ISO | RGD:732751 | 6480464 | Atrazine results in increased expression of NR4A1 mRNA | CTD | PMID:18461179 | benzene | decreases expression | ISO | RGD:732752 | 6480464 | Benzene results in decreased expression of NR4A1 mRNA | CTD | PMID:15120971 PMID:15122651 | benzene | decreases expression | ISO | RGD:732752 | 6480464 | Benzene results in decreased expression of NR4A1 mRNA | CTD | PMID:15122651 PMID:15120971 | benzo[a]pyrene | decreases expression | ISO | RGD:732752 | 6480464 | Benzo(a)pyrene results in decreased expression of NR4A1 mRNA | CTD | PMID:15894712 PMID:20713471 | benzo[a]pyrene | decreases expression | ISO | RGD:732751 | 6480464 | Benzo(a)pyrene results in decreased expression of NR4A1 mRNA | CTD | PMID:22178795 | benzo[a]pyrene | increases expression | ISO | RGD:732751 | 6480464 | Benzo(a)pyrene results in increased expression of NR4A1 mRNA | CTD | PMID:22316170 | benzo[a]pyrene | increases expression | ISO | RGD:732752 | 6480464 | Benzo(a)pyrene results in increased expression of NR4A1 mRNA | CTD | PMID:21569818 | benzo[a]pyrene | decreases expression | ISO | RGD:732752 | 6480464 | Benzo(a)pyrene results in decreased expression of NR4A1 mRNA | CTD | PMID:20713471 PMID:15894712 | benzo[a]pyrene | multiple interactions | ISO | RGD:732752 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of NR4A1 mRNA | CTD | PMID:15894712 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of NR4A1 mRNA | CTD | PMID:15728792 | bisphenol A | increases expression | ISO | RGD:732752 | 6480464 | bisphenol A results in increased expression of NR4A1 mRNA | CTD | PMID:20826375 PMID:12021184 | bisphenol A | multiple interactions | ISO | RGD:732752 | 6480464 | [bisphenol A results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of NR4A1 mRNA; more ... | CTD | PMID:12021184 | bisphenol A | increases expression | ISO | RGD:732752 | 6480464 | bisphenol A results in increased expression of NR4A1 mRNA | CTD | PMID:12021184 PMID:20826375 | bisphenol A | affects expression | ISO | RGD:732751 | 6480464 | bisphenol A affects the expression of NR4A1 mRNA | CTD | PMID:20170705 | cadmium atom | multiple interactions | ISO | RGD:732751 | 6480464 | NR4A1 mutant form inhibits the reaction [Cadmium results in increased expression of BAX mRNA] | CTD | PMID:15016657 | cadmium atom | increases expression | ISO | RGD:732751 | 6480464 | Cadmium results in increased expression of NR4A1 mRNA | CTD | PMID:22562489 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NR4A1 mRNA | CTD | PMID:19010381 | cadmium sulfate | increases expression | ISO | RGD:732751 | 6480464 | cadmium sulfate results in increased expression of NR4A1 mRNA | CTD | PMID:21783983 | calcitriol | multiple interactions | ISO | RGD:732751 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of NR4A1 mRNA | CTD | PMID:21592394 | calcitriol | increases expression | ISO | RGD:732751 | 6480464 | Calcitriol results in increased expression of NR4A1 mRNA | CTD | PMID:21592394 | carbonyl sulfide | affects expression | EXP | | 6480464 | carbonyl sulfide affects the expression of NR4A1 mRNA | CTD | PMID:19395590 | chloroprene | decreases expression | ISO | RGD:732752 | 6480464 | Chloroprene results in decreased expression of NR4A1 mRNA | CTD | PMID:23125180 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of NR4A1 mRNA | CTD | PMID:18668222 | cisplatin | affects response to substance | ISO | RGD:732751 | 6480464 | NR4A1 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of NR4A1 mRNA | CTD | PMID:10987852 PMID:19695244 | clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of NR4A1 mRNA | CTD | PMID:11564422 PMID:10987852 | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of NR4A1 mRNA | CTD | PMID:19695244 PMID:10987852 | clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of NR4A1 mRNA | CTD | PMID:10987852 PMID:11564422 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of NR4A1 mRNA | CTD | PMID:12358776 more ... | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of NR4A1 mRNA | CTD | PMID:12358776 more ... | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of NR4A1 mRNA | CTD | PMID:20187946 more ... | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of NR4A1 mRNA | CTD | PMID:12117546 | copper atom | increases expression | ISO | RGD:732751 | 6480464 | Copper results in increased expression of NR4A1 mRNA | CTD | PMID:19747488 | copper(0) | increases expression | ISO | RGD:732751 | 6480464 | Copper results in increased expression of NR4A1 mRNA | CTD | PMID:19747488 | copper(2+) sulfate | increases expression | ISO | RGD:732751 | 6480464 | Copper Sulfate results in increased expression of NR4A1 mRNA | CTD | PMID:19549813 | crocidolite asbestos | increases expression | ISO | RGD:732751 | 6480464 | Asbestos, Crocidolite results in increased expression of NR4A1 mRNA | CTD | PMID:18687144 | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide promotes the reaction [LHB protein results in increased expression of NR4A1 mRNA] | CTD | PMID:11416027 | cyclosporin A | multiple interactions | ISO | RGD:732751 | 6480464 | Cyclosporine inhibits the reaction [cadmium acetate results in increased expression of NR4A1 protein] | CTD | PMID:15016657 | D-glucopyranose 6-phosphate | multiple interactions | ISO | RGD:732752 | 6480464 | [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA | CTD | PMID:20505214 | D-penicillamine | increases expression | EXP | | 6480464 | Penicillamine results in increased expression of NR4A1 mRNA | CTD | PMID:19575532 | dapsone | multiple interactions | ISO | RGD:732751 | 6480464 | Dapsone analog inhibits the reaction [Metribolone results in increased expression of NR4A1 mRNA] | CTD | PMID:21440447 | Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:732752 | 6480464 | Tetrahydrocannabinol results in increased expression of NR4A1 mRNA | CTD | PMID:21955143 | dexamethasone | multiple interactions | ISO | RGD:732752 | 6480464 | Dexamethasone inhibits the reaction [Pentylenetetrazole results in increased expression of NR4A1 mRNA] | CTD | PMID:8164692 | dexamethasone | affects localization | EXP | | 6480464 | Dexamethasone affects the localization of NR4A1 protein | CTD | PMID:16403471 | diarsenic trioxide | decreases expression | ISO | RGD:732751 | 6480464 | arsenic trioxide results in decreased expression of NR4A1 mRNA | CTD | PMID:20458559 | diazoxide | decreases expression | ISO | RGD:732752 | 6480464 | Isoproterenol results in decreased expression of NR4A1 mRNA | CTD | PMID:20003209 | dibutyl phthalate | increases expression | ISO | RGD:732752 | 6480464 | Dibutyl Phthalate results in increased expression of NR4A1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | ISO | RGD:732752 | 6480464 | Dibutyl Phthalate results in increased expression of NR4A1 mRNA | CTD | PMID:17361019 PMID:21266533 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of NR4A1 mRNA | CTD | PMID:21266533 | dichlorine | decreases expression | EXP | | 6480464 | Chlorine results in decreased expression of NR4A1 mRNA | CTD | PMID:18636392 | dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of NR4A1 mRNA | CTD | PMID:18636392 | dipentyl phthalate | increases expression | EXP | | 6480464 | di-n-pentyl phthalate results in increased expression of NR4A1 mRNA | CTD | PMID:15728792 | doxorubicin | affects expression | ISO | RGD:732751 | 6480464 | Doxorubicin affects the expression of NR4A1 mRNA | CTD | PMID:15205334 | doxorubicin | multiple interactions | ISO | RGD:732752 | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of NR4A1 mRNA | CTD | PMID:21040762 | doxorubicin | increases expression | ISO | RGD:732752 | 6480464 | Doxorubicin results in increased expression of NR4A1 mRNA | CTD | PMID:21040762 | doxorubicin | decreases response to substance | ISO | RGD:732751 | 6480464 | NR4A1 mRNA results in decreased susceptibility to Doxorubicin | CTD | PMID:16322897 | ethanol | increases expression | ISO | RGD:732752 | 6480464 | Ethanol results in increased expression of NR4A1 mRNA | CTD | PMID:21955143 | fenofibrate | multiple interactions | ISO | RGD:732751 | 6480464 | Fenofibrate inhibits the reaction [NR4A1 protein results in increased expression of SERPINE1 mRNA]; more ... | CTD | PMID:19593819 | fenthion | increases expression | ISO | RGD:732751 | 6480464 | Fenthion results in increased expression of NR4A1 | CTD | PMID:21538558 | fulvestrant | increases expression | ISO | RGD:732751 | 6480464 | fulvestrant results in increased expression of NR4A1 mRNA | CTD | PMID:16514628 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of NR4A1 gene | CTD | PMID:22079235 | genistein | decreases expression | ISO | RGD:732751 | 6480464 | Genistein results in decreased expression of NR4A1 mRNA | CTD | PMID:16705744 | genistein | increases expression | ISO | RGD:732751 | 6480464 | Genistein results in increased expression of NR4A1 mRNA | CTD | PMID:23019147 | glycerol | multiple interactions | ISO | RGD:732752 | 6480464 | [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA | CTD | PMID:20505214 | gold atom | multiple interactions | ISO | RGD:732752 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA | CTD | PMID:19695318 | gold(0) | multiple interactions | ISO | RGD:732752 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA | CTD | PMID:19695318 | haloperidol | affects response to substance | ISO | RGD:732752 | 6480464 | NR4A1 affects the susceptibility to Haloperidol | CTD | PMID:14603264 | haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of NR4A1 mRNA | CTD | PMID:19695244 PMID:10987852 | haloperidol | multiple interactions | EXP | | 6480464 | 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of NR4A1 mRNA] | CTD | PMID:19695244 | haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of NR4A1 mRNA | CTD | PMID:10987852 PMID:19695244 | haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of NR4A1 mRNA | CTD | PMID:11564422 | hydrogen peroxide | affects expression | ISO | RGD:732751 | 6480464 | Hydrogen Peroxide affects the expression of NR4A1 mRNA | CTD | PMID:20044591 | hydrogen peroxide | increases expression | ISO | RGD:732751 | 6480464 | Hydrogen Peroxide results in increased expression of NR4A1 mRNA | CTD | PMID:12414654 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of NR4A1 mRNA | CTD | PMID:21396975 | indomethacin | increases expression | ISO | RGD:732751 | 6480464 | Indomethacin results in increased expression of NR4A1 mRNA | CTD | PMID:10919358 | indomethacin | multiple interactions | ISO | RGD:732751 | 6480464 | Indomethacin results in increased expression of and results in increased activity of NR4A1 protein; more ... | CTD | PMID:10919358 | isoprenaline | decreases expression | ISO | RGD:732752 | 6480464 | Isoproterenol results in decreased expression of NR4A1 mRNA | CTD | PMID:20003209 | kainic acid | decreases expression | ISO | RGD:732752 | 6480464 | Kainic Acid results in decreased expression of NR4A1 mRNA | CTD | PMID:17997037 | kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of NR4A1 mRNA | CTD | PMID:19700661 | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of NR4A1 mRNA | CTD | PMID:22641619 | leptomycin B | multiple interactions | ISO | RGD:732751 | 6480464 | leptomycin B inhibits the reaction [Tretinoin affects the localization of [NR4A1 protein binds to RXRA protein]] | CTD | PMID:14592536 | maneb | multiple interactions | ISO | RGD:732752 | 6480464 | [Paraquat co-treated with Maneb] affects the expression of NR4A1 mRNA | CTD | PMID:22563483 | menadione | affects expression | ISO | RGD:732751 | 6480464 | Vitamin K 3 affects the expression of NR4A1 mRNA | CTD | PMID:20044591 | menadione | increases expression | ISO | RGD:732751 | 6480464 | Vitamin K 3 results in increased expression of NR4A1 mRNA | CTD | PMID:12414654 | mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of NR4A1 mRNA | CTD | PMID:12730625 | mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of NR4A1 mRNA | CTD | PMID:12730625 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of NR4A1 mRNA | CTD | PMID:15644446 | mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:732751 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of NR4A1 mRNA | CTD | PMID:19822197 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:732751 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of NR4A1 mRNA | CTD | PMID:23118965 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:732752 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of NR4A1 mRNA | CTD | PMID:22401849 | morphine | increases expression | ISO | RGD:732752 | 6480464 | Morphine results in increased expression of NR4A1 mRNA | CTD | PMID:21955143 | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of NR4A1 mRNA | CTD | PMID:17032414 | nickel atom | increases expression | ISO | RGD:732752 | 6480464 | Nickel results in increased expression of NR4A1 mRNA | CTD | PMID:12540486 | nickel sulfate | increases expression | ISO | RGD:732751 | 6480464 | nickel sulfate results in increased expression of NR4A1 mRNA | CTD | PMID:16780908 | nicotinamide | multiple interactions | ISO | RGD:732752 | 6480464 | [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA | CTD | PMID:20505214 | nitric oxide | increases expression | EXP | | 6480464 | Nitric Oxide results in increased expression of NR4A1 mRNA | CTD | PMID:10460269 | ozone | multiple interactions | ISO | RGD:732752 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Ozone results in increased expression of NR4A1 mRNA] | CTD | PMID:17460151 | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of NR4A1 mRNA | CTD | PMID:16716893 | ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of NR4A1 mRNA | CTD | PMID:18636392 | paracetamol | affects expression | ISO | RGD:732752 | 6480464 | Acetaminophen affects the expression of NR4A1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:732752 | 6480464 | Acetaminophen results in increased expression of NR4A1 mRNA | CTD | PMID:11264010 | paraquat | increases expression | ISO | RGD:732752 | 6480464 | Paraquat results in increased expression of NR4A1 mRNA | CTD | PMID:12595580 | paraquat | multiple interactions | ISO | RGD:732752 | 6480464 | [Paraquat co-treated with Maneb] affects the expression of NR4A1 mRNA | CTD | PMID:22563483 | paraquat | decreases expression | ISO | RGD:732752 | 6480464 | Paraquat results in decreased expression of NR4A1 mRNA | CTD | PMID:22563483 | paricalcitol | multiple interactions | ISO | RGD:732751 | 6480464 | [Phosphorus co-treated with paricalcitol] affects the expression of NR4A1 mRNA | CTD | PMID:17715259 | pentobarbital | multiple interactions | EXP | | 6480464 | Chorionic Gonadotropin inhibits the reaction [Pentobarbital results in decreased expression of NR4A1 mRNA] | CTD | PMID:11416027 | pentobarbital | decreases expression | EXP | | 6480464 | Pentobarbital results in decreased expression of NR4A1 mRNA | CTD | PMID:11416027 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of NR4A1 mRNA | CTD | PMID:19162173 | phenobarbital | decreases expression | ISO | RGD:732752 | 6480464 | Phenobarbital results in decreased expression of NR4A1 mRNA | CTD | PMID:19270015 | phorbol 13-acetate 12-myristate | affects localization | ISO | RGD:732751 | 6480464 | Tetradecanoylphorbol Acetate affects the localization of NR4A1 protein | CTD | PMID:12376465 | phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:732751 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NR4A1 mRNA | CTD | PMID:12376465 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732751 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA | CTD | PMID:16979875 | phosphorus atom | multiple interactions | ISO | RGD:732751 | 6480464 | [Phosphorus co-treated with paricalcitol] affects the expression of NR4A1 mRNA | CTD | PMID:17715259 | phosphorus(.) | multiple interactions | ISO | RGD:732751 | 6480464 | [Phosphorus co-treated with paricalcitol] affects the expression of NR4A1 mRNA | CTD | PMID:17715259 | pioglitazone | increases expression | ISO | RGD:732752 | 6480464 | pioglitazone results in increased expression of NR4A1 mRNA | CTD | PMID:17785466 | potassium atom | increases expression | EXP | | 6480464 | Potassium results in increased expression of NR4A1 mRNA | CTD | PMID:10693946 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of NR4A1 mRNA | CTD | PMID:19162173 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:732752 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of NR4A1 mRNA | CTD | PMID:22698814 | progesterone | increases expression | ISO | RGD:732751 | 6480464 | Progesterone results in increased expression of NR4A1 mRNA | CTD | PMID:18037150 | progesterone | multiple interactions | ISO | RGD:732752 | 6480464 | NR4A1 protein mutant form inhibits the reaction [bisphenol A results in increased abundance of Progesterone]; more ... | CTD | PMID:12021184 | progesterone | multiple interactions | ISO | RGD:732752 | 6480464 | NR4A1 protein promotes the reaction [2,2-bis(4-glycidyloxyphenyl)propane affects the abundance of Progesterone] | CTD | PMID:18525235 | pyridaben | decreases expression | ISO | RGD:732752 | 6480464 | pyridaben results in decreased expression of NR4A1 mRNA | CTD | PMID:22563483 | quercetin | increases expression | ISO | RGD:732751 | 6480464 | Quercetin results in increased expression of NR4A1 mRNA | CTD | PMID:21632981 | raloxifene | increases expression | ISO | RGD:732751 | 6480464 | Raloxifene results in increased expression of NR4A1 mRNA | CTD | PMID:16514628 | ranitidine | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NR4A1 mRNA | CTD | PMID:16415329 | rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of NR4A1 mRNA | CTD | PMID:21515302 | scopolamine | decreases expression | EXP | | 6480464 | Scopolamine Hydrobromide results in decreased expression of NR4A1 mRNA | CTD | PMID:17540011 | sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of NR4A1 mRNA | CTD | PMID:15967596 | silicon dioxide | increases expression | ISO | RGD:732752 | 6480464 | Silicon Dioxide results in increased expression of NR4A1 mRNA | CTD | PMID:19073995 | succinic acid | multiple interactions | ISO | RGD:732752 | 6480464 | [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA | CTD | PMID:20505214 | tamoxifen | affects expression | ISO | RGD:732752 | 6480464 | Tamoxifen affects the expression of NR4A1 mRNA | CTD | PMID:17555576 | terbufos | increases expression | ISO | RGD:732751 | 6480464 | terbufos results in increased expression of NR4A1 | CTD | PMID:21538558 | tert-butyl hydroperoxide | increases expression | ISO | RGD:732751 | 6480464 | tert-Butylhydroperoxide results in increased expression of NR4A1 mRNA | CTD | PMID:12414654 | testosterone | multiple interactions | ISO | RGD:732751 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of NR4A1 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | RGD:732751 | 6480464 | Testosterone results in increased expression of NR4A1 mRNA | CTD | PMID:21592394 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of NR4A1 mRNA | CTD | PMID:17032414 | thalidomide | increases expression | ISO | RGD:732751 | 6480464 | Thalidomide analog results in increased expression of NR4A1 mRNA | CTD | PMID:20525221 | thimerosal | increases expression | ISO | RGD:732751 | 6480464 | Thimerosal results in increased expression of NR4A1 mRNA | CTD | PMID:16870260 | trichostatin A | multiple interactions | ISO | RGD:732751 | 6480464 | [Fenretinide co-treated with trichostatin A] affects the localization of NR4A1 protein; more ... | CTD | PMID:21319187 | trichostatin A | increases expression | ISO | RGD:732751 | 6480464 | trichostatin A results in increased expression of NR4A1 mRNA; more ... | CTD | PMID:21319187 | trichostatin A | affects localization | ISO | RGD:732751 | 6480464 | trichostatin A affects the localization of NR4A1 protein | CTD | PMID:21319187 | troglitazone | increases expression | ISO | RGD:732752 | 6480464 | troglitazone results in increased expression of NR4A1 mRNA | CTD | PMID:17785466 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of NR4A1 mRNA | CTD | PMID:21515302 | undecane | increases expression | EXP | | 6480464 | undecane results in increased expression of NR4A1 protein | CTD | PMID:17337753 | zinc atom | multiple interactions | ISO | RGD:732751 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA | CTD | PMID:16979875 | zinc atom | multiple interactions | ISO | RGD:732751 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NR4A1 mRNA | CTD | PMID:18593933 | zinc atom | increases expression | ISO | RGD:732751 | 6480464 | Zinc deficiency results in increased expression of NR4A1 mRNA | CTD | PMID:18356318 | zinc(0) | multiple interactions | ISO | RGD:732751 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA | CTD | PMID:16979875 | zinc(0) | increases expression | ISO | RGD:732751 | 6480464 | Zinc deficiency results in increased expression of NR4A1 mRNA | CTD | PMID:18356318 | zinc(0) | multiple interactions | ISO | RGD:732751 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NR4A1 mRNA | CTD | PMID:18593933 | |
Gene Ontology AnnotationsBiological Process











